Ferrous Fumarate Specification and COA: Essential Quality Assurance Guidelines

application 2025-12-20

Ferrous Fumarate Specification and COA: Key Details for Quality Assurance

Ferrous fumarate is a widely used iron supplement known for its high bioavailability and effectiveness in treating iron deficiency anemia. To ensure product quality, manufacturers and buyers must adhere to strict ferrous fumarate specifications and review the Certificate of Analysis (COA) before procurement.

Ferrous Fumarate Specification Overview
Ferrous fumarate must meet pharmacopeial standards (USP, BP, or EP) with the following key parameters:
– Chemical Formula: C₄H₂FeO₄
– Assay (Purity): ≥97.0% (anhydrous basis)
– Iron Content: 32.5–33.5%
– Loss on Drying: ≤1.5%
– Heavy Metals: ≤20 ppm (as per USP)
– Sulfate Residue: ≤0.2%
– Particle Size: As per application requirements

Importance of COA for Ferrous Fumarate
A Certificate of Analysis (COA) is a critical document verifying that the product meets regulatory and quality standards. Key COA details include:
– Batch/Lot Number for traceability
– Manufacturer’s Compliance (USP/BP/EP)
– Test Results (assay, heavy metals, microbial limits)
– Expiry Date & Storage Conditions

Why Compliance Matters
Adhering to ferrous fumarate specifications ensures:
– Safety: Low impurity levels prevent toxicity risks.
– Efficacy: Proper iron content guarantees therapeutic effectiveness.
– Regulatory Approval: Compliance with USP/BP/EP standards is mandatory for pharmaceutical use.

Conclusion
When sourcing ferrous fumarate, always verify the specification sheet and COA to ensure quality, safety, and regulatory compliance. Reliable suppliers provide transparent documentation, helping buyers make informed decisions.